Bairuiqi Biology
Latest round
- Series A
Last raised
- Mar 2017
Total raised
- Undisclosed
Investors
- 2
About Bairuiqi Biology
Established in 2013 and based in Beijing, China, Bairuiqi Biology is a monoclonal antibody developer. The company mainly develops monoclonal antibodies and provides users with solutions for the treatment of fibrotic diseases. The company generates revenue by providing monoclonal antibody and solution of treating fibrosis for patients.
Who invested in Bairuiqi Biology
2 investors across 1 round
See all investors in Bairuiqi Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 20, 2017
Amount
Undisclosed
Investors
Questions about Bairuiqi Biology
Who invested in Bairuiqi Biology?
Bairuiqi Biology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bairuiqi Biology raised?
Bairuiqi Biology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bairuiqi Biology last raise money?
Bairuiqi Biology's most recent round on record is a Series A, in Mar 2017.
What does Bairuiqi Biology do?
Established in 2013 and based in Beijing, China, Bairuiqi Biology is a monoclonal antibody developer.
Where is Bairuiqi Biology headquartered?
Bairuiqi Biology is headquartered in Beijing, China.
Which VCs invest in companies like Bairuiqi Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Bairuiqi Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bairuiqi Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.